SGP
SpyGlass Pharma, Inc.
NASDAQ: SGP · HEALTHCARE · BIOTECHNOLOGY
$22.94
+3.66% today
Updated 2026-04-30
Market cap
$786.19M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.25
Dividend yield
—
52W range
$20 – $32
Volume
0.1M
SpyGlass Pharma, Inc. (SGP) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |